Emerging preclinical evidence indicates that pharmacological induction of tumor pyroptosis promotes immune responses, representing a new therapeutic avenue for relapsed/refractory cancer patients. For example, a recent study in Communications Medicine has demo... ...

请注册登录后继续浏览